We started with the introduction to the Flamin-go project by the project leader professor Annalisa Chiocchetti.

From pathobiology to synovia on a chip: driving rheumatoid arthritis to the precision medicine goal FLAMIN-GO aims at developing a joint-on-a-chip built with cells and tissues derived from the patient’s biopsy. It aims to mimic the pathophysiology of rheumatoid arthritis, an autoimmune disease characterized by inflammation and pain in the joints. Development of a joint-on-a-chip will allow selecting the best drug on the market to initiate the proper treatment and avoid unnecessary exposure of the patient to potentially toxic and non-responsive drugs.